Subgroup analysis of Japanese patients in a phase III randomized, controlled study of neoadjuvant atezolizumab or placebo, combined with nab-paclitaxel and anthracycline-based chemotherapy in early triple-negative breast cancer (IMpassion031)
暂无分享,去创建一个
N. Masuda | N. Niikura | N. Hayashi | S. Ohsumi | M. Hattori | S. Saji | T. Yamashita | Mitsuya Ito | A. Hasegawa | K. Kobayashi | Keiichi Kiyama | S. Nakagawa